[Balloon-occluded arterial infusion as chemotherapy in bladder cancer--long-term results].
One hundred three patients with bladder cancer underwent balloon-occluded arterial infusion. In 66 patients whose therapeutic effects could be evaluated by endoscope, CT and angiography, the anti-tumor effective rate (CR + PR) was 78.8%. In 15 patients who were not treated by trans-urethral resection or total cystectomy but BOAI, one-year cumulative survival rate was 46.7% and the two-year rate 13.3%. The longest survival period after BOAI was 7 years and 8 months. 133Xe activity of bladder tumor area in BOAI was 6.60 times higher than in simple arterial infusion. BOAI was thought to be a promising conservative treatment in advanced bladder cancer.
Mitsuzane
K
K
Dept. of Radiology, National Sengokuso Hospital.
Kawabata
M
M
Terada
M
M
Nomura
S
S
Sato
M
M
Yamada
R
R
D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002295:Carcinoma, Transitional Cell / Q000401:mortality / Q000628:therapy*; D002404:Catheterization; D002945:Cisplatin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007261:Infusions, Intra-Arterial; D008297:Male; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D011379:Prognosis; D015996:Survival Rate; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000628:therapy*
D008937:Mitomycins; D016685:Mitomycin; D004317:Doxorubicin; D002945:Cisplatin